Shanghai Fosun Pharmaceutical Group Co Eulerpool naujienos

Shanghai Fosun Pharmaceutical Group Co Eulerpool News

Shanghai Fosun Pharmaceutical Group Co akcijų naujienos

Shanghai Fosun Pharmaceutical Group Co stebi daugybė žurnalistų ir investuotojų visame pasaulyje. Naujausias Shanghai Fosun Pharmaceutical Group Co naujienas mes pateikiame čia.

• rugpjūčio 28 d. ·

  Yahoo
  Fosun Pharma Announces 2024 Interim Results
• balandžio 26 d. ·

  Yahoo
  Fosun Pharma's Self-developed Artemisinin Medicines Inject New Impetus to Malaria Prevention and Treatment in Africa
• kovo 8 d. ·

  SeekingAlpha
  Fosun Tourism At Crossroads As Parent Shops Its Two Major Assets
• gruodžio 17 d. ·

  SeekingAlpha
  Week In Review: SystImmune Out-Licenses Global Rights For ADC To BMS In $8.4B Deal
• gruodžio 15 d. ·

  Yahoo
  Fosun’s Hospital Arm Weighs $141 Million Funding Round, Sources Say
• gruodžio 14 d. ·

  Yahoo
  Fosun Pharma's Global Multi-Center Phase III Clinical Trial Project for A New Antimalarial Drug Receives 500 Million Japanese Yen Investment from GHIT Fund to Jointly Improve the Global Accessibility of Antimalarial Drugs
• lapkričio 12 d. ·

  Yahoo
  Fosun Pharma prepares to deliver Da Vinci surgical robots to make advanced medical treatment affordable to Chinese patients
• rugsėjo 20 d. ·

  Yahoo
  Cevira Phase III trial for non-surgical HSIL treatment meets primary endpoint
• rugsėjo 7 d. ·

  SeekingAlpha
  Debt Pressures Cast Cloud Over Fosun Pharma Results
• rugpjūčio 30 d. ·

  Yahoo
  Fosun Pharma Announces 2023 Interim Results: Continues to Promote Innovation Transformation and Optimizes Product Structure